These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Successful use of brachytherapy for a severe hidradenitis suppurativa variant. Paul S; Bach D; LeBoeuf NR; Devlin PM; Lipworth AD Dermatol Ther; 2016 Nov; 29(6):455-458. PubMed ID: 27425163 [TBL] [Abstract][Full Text] [Related]
45. Chronic hidradenitis suppurativa in the inguinal, perineal and scrotal regions. A case report and review of the literature. Pironi D; Caruso F; Panarese A; Vendettuoli M; Mascagni D; Moraldi L; Filippini A Ann Ital Chir; 2010; 81(6):465-70. PubMed ID: 21456485 [TBL] [Abstract][Full Text] [Related]
46. Interstitial keratitis secondary to severe hidradenitis suppurativa: a case report and literature review. Alzaga Fernandez AG; Demirci H; Darnley-Fisch DA; Steen DW Cornea; 2010 Oct; 29(10):1189-91. PubMed ID: 20628295 [TBL] [Abstract][Full Text] [Related]
47. Hidradenitis suppurativa and Crohn's disease: two cases that support an association. Yazdanyar S; Miller IM; Jemec GB Acta Dermatovenerol Alp Pannonica Adriat; 2010 Oct; 19(3):23-5. PubMed ID: 20976417 [TBL] [Abstract][Full Text] [Related]
48. Hidradenitis suppurativa and perianal Crohn disease: differential diagnosis. Bassas-Vila J; González Lama Y Actas Dermosifiliogr; 2016 Sep; 107 Suppl 2():27-31. PubMed ID: 28081767 [TBL] [Abstract][Full Text] [Related]
50. Congenital nevus comedonicus complicated by a hidradenitis suppurativa-like lesion: Report of a childhood case. Ravaioli GM; Neri I; Zannetti G; Patrizi A Pediatr Dermatol; 2018 Sep; 35(5):e298-e299. PubMed ID: 29952017 [TBL] [Abstract][Full Text] [Related]
51. Squamous cell carcinoma arising in long-standing hidradenitis suppurativa: An overlooked facet of the immunocompromised district. Fabbrocini G; Ruocco E; De Vita V; Monfrecola G Clin Dermatol; 2017; 35(2):225-227. PubMed ID: 28274364 [TBL] [Abstract][Full Text] [Related]
52. Effectiveness of 5-aminolevulinic acid photodynamic therapy in the treatment of hidradenitis suppurativa: a report of 5 cases. Andino Navarrete R; Hasson Nisis A; Parra Cares J Actas Dermosifiliogr; 2014; 105(6):614-7. PubMed ID: 24472519 [TBL] [Abstract][Full Text] [Related]
53. Clinical experience of the use of adalimumab in the management of hidradenitis suppurativa. Comparison of response rates with Crohn disease. Moyano B; Clemente A; Marín-Jiménez I; Martorell A Actas Dermosifiliogr; 2016 Sep; 107 Suppl 2():43-50. PubMed ID: 28081769 [TBL] [Abstract][Full Text] [Related]
54. A comment on rapid progression of hidradenitis suppurativa in the lower leg of a patient with psoriasis vulgaris. Verma P; Chhabra N Acta Derm Venereol; 2012 Jul; 92(4):447. PubMed ID: 22511235 [No Abstract] [Full Text] [Related]
55. Nodulocystic acne and hidradenitis suppurativa treated with acitretin: a case report. Scheman AJ Cutis; 2002 Apr; 69(4):287-8. PubMed ID: 12080949 [TBL] [Abstract][Full Text] [Related]
56. NICE approval of adalimumab for moderate-to-severe hidradenitis suppurativa: the end of the beginning for hidradenitis suppurativa therapeutics? Ingram JR; Burton T Br J Dermatol; 2017 Feb; 176(2):281-282. PubMed ID: 28244073 [No Abstract] [Full Text] [Related]
57. Major gaps in understanding and treatment of hidradenitis suppurativa. Hoffman LK; Ghias MH; Garg A; Hamzavi IH; Alavi A; Lowes MA Semin Cutan Med Surg; 2017 Jun; 36(2):86-92. PubMed ID: 28538750 [TBL] [Abstract][Full Text] [Related]
58. Altered innate and adaptive immune responses in patients with hidradenitis suppurativa. Giamarellos-Bourboulis EJ; Antonopoulou A; Petropoulou C; Mouktaroudi M; Spyridaki E; Baziaka F; Pelekanou A; Giamarellou H; Stavrianeas NG Br J Dermatol; 2007 Jan; 156(1):51-6. PubMed ID: 17199566 [TBL] [Abstract][Full Text] [Related]